Stocks
GlaxoSmithKline (GSK) Revenue US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| Revenue, £ | ? | 29 324 000 000 | 29 324 000 000 | 29 324 000 000 | 30 328 000 000 | 30 328 000 000 | 31 271 000 000 | ||
| Changes by years, y/y, % | -14% | 0% | 0% | +3% | 0% | -0.3% | |||
GlaxoSmithKline. Revenue US GAAP, £
GlaxoSmithKline. Revenue US GAAP, changes, %
GlaxoSmithKline. Revenue US GAAP, sum by quarters, £
GlaxoSmithKline (GSK) Revenue US GAAP (quarter values) |
||||||||
| 2024Q2 | 2024Q1 | 2024Q3 | 2024Q2 | 2024Q3 | LTM ? | |||
| Revenue, £ | ? | 7 884 000 000 | 7 363 000 000 | 8 012 000 000 | 7 884 000 000 | 8 012 000 000 | 31 271 000 000 | |
| Changes by years, y/y, % | +10% | +6% | -2% | +10% | -2% | |||
| Changes by quarters, q/q, % | -2% | -7% | +9% | -2% | +2% | |||
